Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. Orthologous to several human genes including ZNF780A (zinc finger protein 780A); INTERACTS WITH 2-palmitoylglycerol (ortholog); 3-isobutyl-1-methyl-7H-xanthine (ortholog); 4,4'-sulfonyldiphenol (ortholog).
AABR07002774.4; hypothetical protein LOC685578; hypothetical protein LOC687328; LOC102554136; LOC685578; similar to Zinc finger protein 354A (Transcription factor 17) (Renal transcription factor Kid-1) (Kidney, ischemia, and developmentally regulated protein 1); zinc finger protein 59; zinc finger protein 59-like; zinc finger protein 60; zinc finger protein 60-like; zinc finger protein 780A; zinc finger protein 780A-like
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of KRBOX5 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of KRBOX5 mRNA
[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KRBOX5 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KRBOX5 mRNA
[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KRBOX5 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KRBOX5 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of KRBOX5 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of KRBOX5 mRNA
[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KRBOX5 mRNA and [manganese chloride results in increased abundance of Manganese] which results in increased expression of KRBOX5 mRNA
[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KRBOX5 mRNA and [manganese chloride results in increased abundance of Manganese] which results in increased expression of KRBOX5 mRNA
[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KRBOX5 mRNA and [manganese chloride results in increased abundance of Manganese] which results in increased expression of KRBOX5 mRNA
[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KRBOX5 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KRBOX5 mRNA
similar to Zinc finger protein 354A (Transcription factor 17) (Renal transcription factor Kid-1) (Kidney, ischemia, and developmentally regulated protein 1)
similar to Zinc finger protein 354A (Transcription factor 17) (Renal transcription factor Kid-1) (Kidney, ischemia, and developmentally regulated protein 1)